Literature DB >> 8358016

Enhancement by GM-CSF of agonist-induced 5-lipoxygenase activation in human neutrophils involves protein synthesis and gene transcription.

P P McDonald1, M Pouliot, P Borgeat.   

Abstract

We investigated the effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) on the 5-lipoxygenase (5-LO) component of the leukotriene (LT) biosynthetic pathway of human neutrophils, in order to better understand the mechanism whereby the cytokine primes for LT synthesis. We found that GM-CSF increased 5-LO activation elicited by platelet-activating factor (PAF), N-formyl-methionyl-leucyl-phenylalanine (fMLP), C5a, LTB4, IL-8 and calcium ionophore A23187, as determined by using an exogenous substrate. A close correlation was observed between the priming kinetics of GM-CSF on 5-LO activation and on LT synthesis; moreover, the effects of the cytokine on both 5-LO activation and LT synthesis were inhibited when the cells had been exposed to either the protein synthesis inhibitor, cycloheximide (CX), or the transcription inhibitor, actinomycin D (AD), prior to incubation with GM-CSF. These results raise the possibility that the priming by GM-CSF of LT synthesis may involve an effect of the cytokine on 5-LO protein synthesis and gene expression.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8358016

Source DB:  PubMed          Journal:  J Lipid Mediat        ISSN: 0921-8319


  2 in total

1.  Early tyrosine phosphorylation events following adenosine A2A receptor in human neutrophils: identification of regulated pathways.

Authors:  Miriam S Giambelluca; Marc Pouliot
Journal:  J Leukoc Biol       Date:  2017-02-08       Impact factor: 4.962

2.  Impact of anti-inflammatory agents on the gene expression profile of stimulated human neutrophils: unraveling endogenous resolution pathways.

Authors:  Mireille St-Onge; Aline Dumas; Annick Michaud; Cynthia Laflamme; Andrée-Anne Dussault; Marc Pouliot
Journal:  PLoS One       Date:  2009-03-19       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.